✦ LIBER ✦

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer

✍ Scribed by Kaye, S. B.; Poole, C. J.; Danska-Bidzinska, A.; Gianni, L.; Del Conte, G.; Gorbunova, V.; Novikova, E.; Strauss, A.; Moczko, M.; McNally, V. A.; Ross, G.; Vergote, I.

Book ID: 125885238
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 251 KB
Volume: 24
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mds282

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II, randomized, double-blind stu

A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)

✍ Cognetti, F.; Bagnato, A.; Colombo, N.; Savarese, A.; Scambia, G.; Sehouli, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Health-related quality of life outcomes

✍ Robin Pokrzywinski; Angeles Alvarez Secord; Laura J. Havrilesky; Larry E. Puls; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 384 KB

A multicenter, randomized, phase 2 clini

A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer

✍ Angeles Alvarez Secord; Andrew Berchuck; Robert V. Higgins; Lawrence R. Nycum; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

Topotecan and carboplatin in patients wi

Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

✍ Dominique Koensgen; Dirk Stengel; Antje Belau; Peter Klare; Guelten Oskay-Oezcel 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 324 KB

5031 POSTER Combination chemotherapy wit

5031 POSTER Combination chemotherapy with carboplatin and gemcitabine in patients in platinum-resistant ovarian cancer chemotherapy: a phase II study demonstrating inhibition of DNA cross-link repair by gemcitabine

✍ Ledermann, J.A.; Gabra, H.; Jayson, G.C.; Spanswick, V.J.; Rustin, G.J.; Jitlal, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

An open-label, single-arm Phase II study

An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer

✍ Peter G. Rose; Bradley J. Monk; Diane Provencher; Jean Hartney; Philippe Legenne 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 192 KB